BioInvent International AB Publishes Annual Report 2025
Accessnewswire·2026-03-31 10:05
BioInvent International AB Publishes Annual Report 2025 Back to the Newsroom BioInvent International AB Publishes Annual Report 2025 LUND, SE / ACCESS Newswire/ March 31, 2026 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class immunomodulatory antibodies for cancer immunotherapy, today announced that the Annual Report for 2025 has been published. The Annual Report is atta ...